González-Santiago, Santiago http://orcid.org/0000-0002-4787-0236
Saura, Cristina
Ciruelos, Eva
Alonso, José Luis
de la Morena, Pilar
Santisteban Eslava, Marta
Gallegos Sancho, Maria Isabel
de Luna, Alicia
Dalmau, Elsa
Servitja, Sonia
Ruiz Borrego, Manuel
Chacón, José Ignacio
Funding for this research was provided by:
Roche Farma S.A
Article History
Received: 29 May 2020
Accepted: 6 August 2020
First Online: 2 September 2020
Compliance with ethical standards
:
: S. González-Santiago has received speaker honoraria from Amgen, Eisai, Novartis, Roche, Pfizer and AstraZeneca, has served in an advisory role for Amgen, Novartis, Roche, Celgene, AstraZeneca and Pfizer, and has received travel expenses from Pfizer, MSD, and Roche. E. Ciruelos has received personal fees from Roche, Lilly, Novartis, and Pfizer. S. Servitja reported speaker bureau honoraria and travel support from Roche. M. Ruiz Borrego has received a speaker’s grant and has served on the advisory board for Roche. The other authors declare that they do not have any conflict of interest.
: Not applicable as this manuscript does not contain any individual person’s data.
: The study was conducted in accordance with the Declaration of Helsinki and its later amendments. The Research Ethics Committee of Parc Taulí Hospital (Sabadell, Barcelona Spain) approved this study.
: Written informed consent was obtained from all individual participants included in the study to collect data from medical charts retrospectively.